These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8047525)

  • 41. The pros and cons of transdermal nicotine therapy.
    Gourlay S
    Med J Aust; 1994 Feb; 160(3):152-9. PubMed ID: 8295585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review.
    Chelland Campbell S; Moffatt RJ; Stamford BA
    Atherosclerosis; 2008 Dec; 201(2):225-35. PubMed ID: 18565528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of 21 mg transdermal nicotine patches and smoking cessation on heart rate variability.
    Stein PK; Rottman JN; Kleiger RE
    Am J Cardiol; 1996 Apr; 77(9):701-5. PubMed ID: 8651120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomised controlled trial of nasal nicotine spray in smoking cessation.
    Sutherland G; Stapleton JA; Russell MA; Jarvis MJ; Hajek P; Belcher M; Feyerabend C
    Lancet; 1992 Aug; 340(8815):324-9. PubMed ID: 1353803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression.
    Thorsteinsson HS; Gillin JC; Patten CA; Golshan S; Sutton LD; Drummond S; Clark CP; Kelsoe J; Rapaport M
    Neuropsychopharmacology; 2001 Apr; 24(4):350-8. PubMed ID: 11182530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers.
    Gourlay SG; Forbes A; Marriner T; Pethica D; McNeil JJ
    BMJ; 1995 Aug; 311(7001):363-6. PubMed ID: 7640544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transdermal nicotine in smoking cessation. A meta-analysis.
    Li Wan Po A
    Eur J Clin Pharmacol; 1993; 45(6):519-28. PubMed ID: 8157037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A double-blind trial of nicotine patches in smoking cessation].
    Tønnesen P; Nørregaard J; Simonsen K; Säwe U
    Ugeskr Laeger; 1992 Jan; 154(5):251-4. PubMed ID: 1736456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicotine replacement therapy for smoking cessation.
    Silagy C; Lancaster T; Stead L; Mant D; Fowler G
    Cochrane Database Syst Rev; 2001; (3):CD000146. PubMed ID: 11686953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does abstinence from smoking or a transdermal nicotine system influence atracurium-induced neuromuscular block?
    Puura AI; Rorarius MG; Laippala P; Baer GA
    Anesth Analg; 1998 Aug; 87(2):430-3. PubMed ID: 9706945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Weight gain and insulin resistance during nicotine replacement therapy.
    Assali AR; Beigel Y; Schreibman R; Shafer Z; Fainaru M
    Clin Cardiol; 1999 May; 22(5):357-60. PubMed ID: 10326169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.
    Gourlay SG; Benowitz NL; Forbes A; McNeil JJ
    Eur J Clin Pharmacol; 1997; 51(5):407-14. PubMed ID: 9049583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample.
    Hill AL; Roe DJ; Taren DL; Muramoto MM; Leischow SJ
    Nicotine Tob Res; 2000 Aug; 2(3):247-53. PubMed ID: 11082825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial.
    Simon JA; Carmody TP; Hudes ES; Snyder E; Murray J
    Am J Med; 2003 May; 114(7):555-62. PubMed ID: 12753879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Lancaster T
    Cochrane Database Syst Rev; 2008 Jan; (1):CD000146. PubMed ID: 18253970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (2):CD000146. PubMed ID: 10796494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.
    Batra A; Klingler K; Landfeldt B; Friederich HM; Westin A; Danielsson T
    Clin Pharmacol Ther; 2005 Dec; 78(6):689-96. PubMed ID: 16338284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and pharmacokinetic properties of a transdermal nicotine patch.
    Mulligan SC; Masterson JG; Devane JG; Kelly JG
    Clin Pharmacol Ther; 1990 Mar; 47(3):331-7. PubMed ID: 2311334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy.
    Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS
    J Clin Pharmacol; 1998 Jun; 38(6):502-9. PubMed ID: 9650539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.